Related references
Note: Only part of the references are listed.The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series
Naomi Serling--Boyd et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Multidisciplinary Approach to Prevent de novo Hepatitis B in Patients with Rheumatoid Arthritis
Ryu Watanabe et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs
Toshiyuki Watanabe et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
Practice Pattern of Hepatitis B Testing in Rheumatoid Arthritis Patients: A Cross-National Comparison Between the US and Taiwan
Tzu-Chieh Lin et al.
ARTHRITIS CARE & RESEARCH (2018)
Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan
Wataru Fukuda et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions
Rohit Loomba et al.
GASTROENTEROLOGY (2017)
Pretreatment Screening for Hepatitis B Virus Infection in Patients with Systemic Lupus Erythematosus
Ryu Watanabe et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Prevalence of Hepatitis B Virus Infection in Patients with Rheumatic Diseases in Tohoku Area: A Retrospective Multicenter Survey
Ryu Watanabe et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy
Ryu Watanabe et al.
MODERN RHEUMATOLOGY (2013)
Share Paper
